We could not find any results for:
Make sure your spelling is correct or try broadening your search.
C - Provider of Filecoin staking nodes - The company, which was an investment vehicle specialising in biotech and life ...
Clarify Pharma PLC 31 August 2023 The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU...
C - investment vehicle specialising in biotech and life sciences companies - Reports pretax loss in the six months to ...
Clarify Pharma PLC 05 July 2023 05 July 2023 Clarify Pharma PLC ("Clarify Pharma" or "the Company") Results of Annual General Meeting Clarify Pharma (AQSE: PSYC), an...
Clarify Pharma PLC 13 June 2023 13 June 2023 Clarify Pharma PLC ("Clarify Pharma" or "the Company") Notice of Annual General Meeting Clarify Pharma (AQSE: PSYC), an investment...
C - London-based investor in psychedelics companies - Pretax loss for year ended November 30 narrows to GBP1.0 million ...
Clarify Pharma PLC 30 May 2023 Press Release 30 May 2023 Clarify Pharma PLC ("Clarify Pharma" or "The Company") Full Year Results Clarify Pharma (AQSE: PSYC), an investment...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0.125 | 0 | 0 | 0 | DE |
4 | -0.105 | -45.652173913 | 0.23 | 0.4 | 0.06 | 5981333 | 0.18748607 | DE |
12 | -0.305 | -70.9302325581 | 0.43 | 0.625 | 0.06 | 1907088 | 0.19616074 | DE |
26 | -0.4 | -76.1904761905 | 0.525 | 0.625 | 0.06 | 1421025 | 0.25007931 | DE |
52 | -0.645 | -83.7662337662 | 0.77 | 0.86 | 0.06 | 1090274 | 0.31672805 | DE |
156 | -2.7 | -95.5752212389 | 2.825 | 2.825 | 0.06 | 905064 | 0.69936304 | DE |
260 | -2.7 | -95.5752212389 | 2.825 | 2.825 | 0.06 | 905064 | 0.69936304 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions